More importantly, a recent scRNA-seq analysis of fibroblasts from normal pancreas and PDAC provided insights into fibroblast evolution during tumor progression, identifying LRRC15+ CAFs of prognostic significance in immunotherapy clinical trials [97]. This evidence concerns the gene LRRC15 and neoplasm.